Riverbridge Partners’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
EC
GIM
CS
EAM
BG
Riverbridge Partners's EVH Position: Q4 2020 in Review
Riverbridge Partners sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 21,609 shares — an estimated $268K sold.
Riverbridge Partners first reported a position in EVH in Q2 2017 and held it in 14 quarters. The position peaked at $97.5M in Q3 2018. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.
- Riverbridge Partners reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
- Riverbridge Partners sold 21,609 Evolent Health shares in Q4 2020, an estimated $268K.
- Riverbridge Partners first reported a position in Evolent Health in Q2 2017 and held it in 14 quarters.
- Riverbridge Partners's Evolent Health position peaked at $97.5M in Q3 2018.
- 161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.
Based on Riverbridge Partners's 13F filing for Q4 2020, filed 22 Jan 2021.